ASN Press Releases: 2017
Latest Release: HIV+ KIDNEY FAILURE PATIENTS FACE HURDLES IN RECEIVING NECESSARY TRANSPLANTS
Thursday, February 23, 2017
Efforts are needed to understand disparities in access to transplantation among HIV+ waitlist candidates
From 2001 to 2012, HIV+ kidney failure patients on the transplant waiting list were 28% less likely to receive a transplant compared with their HIV- counterparts.
They were half as likely to receive a kidney from a living donor.
More than 30% of HIV+ individuals in the United States have kidney disease, which can progress to kidney failure.
View Press Release
Subscribe to ASN Press Releases
Stay on top of the latest happenings with the Society and in the nephrology world by subscribing to the ASN Press Release RSS Feed.
More Press Releases
- LIMITING SALT CONSUMPTION LOWERS BLOOD PRESSURE IN PATIENTS WITH KIDNEY DISEASE
Receiving advice on limiting salt consumption helped kidney disease patients lower their systolic blood pressure by an average of 11 mmHg.
Limiting salt intake also reduced excess fluid retention that is common among patients with kidney disease.
Thursday, February 16, 2017
- DISCOVERY MAY HELP PREVENT TISSUE SCARRING AND REJECTION OF TRANSPLANTED KIDNEYS
During rejection of a transplanted kidney, certain immune cells transform into connective tissue cells, which produce collagen and other fibers.
Thursday, February 16, 2017
- LANGUAGE BARRIERS MAY INTERFERE WITH ACCESS TO KIDNEY TRANSPLANTATION
English language fluency may be an important predictor of patients’ status on the transplant waiting list
Higher degrees of linguistic isolation were linked with a lower likelihood of transitioning from inactive to active status on the kidney transplant waiting list and with incomplete transplant evaluations.
The association of linguistic isolation appeared to be most influential among Hispanic transplant candidates.
Of the >100,000 candidates on the kidney transplant waiting list in the United States, approximately 30% are in “inactive” status.
Thursday, February 9, 2017
- THE AMERICAN SOCIETY OF NEPHROLOGY PARTNERS WITH THE DEPARTMENT OF VETERANS AFFAIRS TO ADVANCE BEST PRACTICES AND APPROACHES TO KIDNEY DISEASE
The American Society of Nephrology (ASN) is pleased to partner with the Department of Veterans Affairs (VA) to host the upcoming Kidney Innovation Summit. The Summit will take place at the Booz Allen Hamilton Center for Innovation in Washington, DC on February 9–10, 2017.
Wednesday, February 8, 2017
- SKIN SODIUM CONTENT LINKED TO HEART PROBLEMS IN PATIENTS WITH KIDNEY DISEASE
Elevated sodium content in the skin correlates closely with left ventricular hypertrophy in patients with chronic kidney disease.
Heart disease is a leading cause of death in individuals with chronic kidney disease.
Thursday, February 2, 2017
- American Society of Nephrology Statement on US President Donald J. Trump's Executive Order on Immigration
American Society of Nephrology (ASN) President Eleanor D. Lederer, MD, FASN, and the Society’s leadership issued the following statement regarding the January 27, 2017, Presidential Executive Order on Immigration.
Tuesday, January 31, 2017
- DEPRESSION IS UNDER-TREATED IN PATIENTS RECEIVING CHRONIC DIALYSIS
Patients are often not interested in receiving anti-depressant treatment, and kidney specialists are often unwilling to prescribe it.
Thursday, January 26, 2017
- LOW LEVELS OF CIRCULATING PROTEIN LINKED TO KIDNEY FUNCTION DECLINE
Findings suggest potential treatment strategy to protect kidney health
Decreased blood levels of a protein called soluble klothos were linked with an increased likelihood of experiencing kidney function decline in a group elderly well-functioning adults.
Thursday, January 19, 2017
- AMERICAN SOCIETY OF NEPHROLOGY WELCOMES GAO REPORT CONFIRMING URGENT NEED FOR GREATER RESEARCH FUNDING
Report Details Imbalance between Kidney Disease Research and Health Impact
ASN Pledges $7 Million to Prize Competition for Innovative Therapy
Wednesday, January 18, 2017
- TRIAL FINDS ORAL IRON DRUG SAFE AND EFFECTIVE FOR TREATING ANEMIA IN KIDNEY DISEASE PATIENTS
In a phase 3 trial of patients with chronic kidney disease, 52.1% of patients receiving oral ferric citrate experienced a significant boost in hemoglobin levels (a reflection of red blood cell counts) compared with 19.1% of patients receiving placebo.
A treatment effect was seen as early as 1-2 weeks after the start of treatment, and the response was durable.
Thursday, January 12, 2017
- RAJNISH MEHROTRA, MD, FASN TO LEAD THE CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY’S INCOMING EDITORIAL TEAM
Rajnish Mehrotra, MD, FASN, begins his 6-year team as Editor-in-Chief of the Clinical Journal of the American Society of Nephrology (CJASN) on January 1, 2017, alongside an incoming editorial team of 17 highly accomplished nephrology researchers whose expertise spans virtually the entire breadth of clinical research in Nephrology. Dr. Mehrotra and his editorial team will be featured in an #AskASN Twitter chat on February 21st.
Friday, January 6, 2017
- MANY KIDNEY FAILURE PATIENTS LACK ADVANCE DIRECTIVES NEAR THE END OF LIFE
Among nursing home residents in the last year of life, patients with kidney failure were far less likely to have advance directives that put limitations on treatments and designated surrogate decision makers compared with other nursing home residents with serious illnesses.
Advance directives with these components were associated with a lower use of intensive interventions at the end of life.
Nearly all kidney failure patients with an advance directive putting limitations on treatment received end-of-life care that was concordant with their preferences.
Thursday, January 5, 2017
- STRUCTURE OF KIDNEY FAILURE PATIENTS’ BLOOD CLOTS MAY INCREASE THEIR RISK OF EARLY DEATH
STRUCTURE OF KIDNEY FAILURE PATIENTS’ BLOOD CLOTS MAY INCREASE THEIR RISK OF EARLY DEATH
Thursday, January 5, 2017